Your search returned over 250 studies. The top 250 studies are being displayed. Please use additional keywords or decrease the search distance. Get alerts for new studies
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Gresham, Oregon
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Clackamas, Oregon
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Milwaukie, Oregon
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Oregon City, Oregon
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Portland, Oregon
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Portland, Oregon
- Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)
Conditions: Pulmonary Hypertension
Location: Portland, Oregon
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Clackamas, Oregon
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Milwaukie, Oregon
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Oregon City, Oregon
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Portland, Oregon
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Portland, Oregon
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Clackamas, Oregon
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Milwaukie, Oregon
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Oregon City, Oregon
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Portland, Oregon
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Portland, Oregon
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Clackamas, Oregon
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Gresham, Oregon
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Milwaukie, Oregon
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Oregon City, Oregon
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Portland, Oregon
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Portland, Oregon
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Clackamas, Oregon
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Milwaukie, Oregon
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Oregon City, Oregon
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Portland, Oregon
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Portland, Oregon
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: Clackamas, Oregon
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: Milwaukie, Oregon
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: Oregon City, Oregon
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: Portland, Oregon
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: Portland, Oregon
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Clackamas, Oregon
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Milwaukie, Oregon
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Oregon City, Oregon
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Portland, Oregon
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Portland, Oregon
- Randomized On-X Anticoagulation Trial
Conditions: Heart Valve Disease
Location: Portland, Oregon
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Clackamas, Oregon
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Milwaukie, Oregon
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Oregon City, Oregon
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Portland, Oregon
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Clackamas, Oregon
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Gresham, Oregon
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Milwaukie, Oregon
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Oregon City, Oregon
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Portland, Oregon
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Portland, Oregon
- Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Stage IIA, Stage IIIA, or Stage IIIB Rectal Cancer
Conditions: Colorectal Cancer
Location: Portland, Oregon
- Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Can
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer
Location: Portland, Oregon
- Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Location: Clackamas, Oregon
- Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Location: Oregon City, Oregon
- Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Location: Portland, Oregon
- Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Location: Portland, Oregon
- Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Conditions: Lung Cancer - Non Small Cell Lung Cancer
Location: Portland, Oregon
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Clackamas, Oregon
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Gresham, Oregon
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Milwaukie, Oregon
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Oregon City, Oregon
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Portland, Oregon
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Portland, Oregon
- Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: Portland, Oregon
- Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Clackamas, Oregon
- Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Milwaukie, Oregon
- Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Oregon City, Oregon
- Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Portland, Oregon
- Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Portland, Oregon
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Clackamas, Oregon
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Milwaukie, Oregon
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Oregon City, Oregon
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Portland, Oregon
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Portland, Oregon
- Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA
Conditions: Impetigo - Secondarily-infected Traumatic Lesions - Skin Diseases, Bacterial
Location: Gresham, Oregon
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Clackamas, Oregon
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Oregon City, Oregon
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Portland, Oregon
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Portland, Oregon
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Portland, Oregon
- Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic FOLFOX6
Conditions: Colon Cancer With Metastases to the Liver
Location: Portland, Oregon
- Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Conditions: Asthma
Location: Portland, Oregon
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Clackamas, Oregon
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Milwaukie, Oregon
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Oregon City, Oregon
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Portland, Oregon
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Portland, Oregon
- A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1
Conditions: Advanced Malignancies
Location: Portland, Oregon
- nContactSurgical Numeris-AF Tethered Coagulation System for Treatment of Longstanding Persistent Atrial Fibrillation (AF)
Conditions: Atrial Fibrillation
Location: Portland, Oregon
- Vaccination of Melanoma Patients With Total or CD25-depleted Peripheral Blood Mononuclear Cell (PBMC)
Conditions: Melanoma
Location: Portland, Oregon
- Home-Based Programs for Improving Sleep in Cancer Survivors
Conditions: Cancer Survivor - Fatigue - Psychosocial Effects of Cancer and Its Treatment - Sleep Disorders
Location: Portland, Oregon
- A Study of RO5185426 in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3)
Conditions: Malignant Melanoma
Location: Portland, Oregon
- Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Conditions: Non-squamous Non-small Cell Lung Cancer
Location: Portland, Oregon
- Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Clackamas, Oregon
- Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Milwaukie, Oregon
- Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Oregon City, Oregon
- Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Portland, Oregon
- Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Portland, Oregon
- Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant
Conditions: Solid Tumors - Glioblastoma Multiforme - Recurrent Malignant Gliomas
Location: Portland, Oregon
- Prospective Multicenter Human Randomized Controlled Evaluation of NOTES® Cholecystectomy
Conditions: Gall Bladder Diseases
Location: Portland, Oregon
- A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
Conditions: Hypertension, Pulmonary
Location: Portland, Oregon
- Endolumenal Partial Myotomy for Esophageal Motility Disorders
Conditions: Esophageal Motility Disorders
Location: Portland, Oregon
- Monoclonal Antibody to OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer
Conditions: Prostate Cancer Metastatic - Cancer of the Prostate - Prostate Cancer
Location: Portland, Oregon
- Radiation Therapy, Tadalafil, Sargramostim, Gemcitabine, and Telomerase Vaccine (GV1001) in Patients With Pancreatic Cancer
Conditions: Locally Advanced Pancreatic Adenocarcinoma
Location: Portland, Oregon
- Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma.
Conditions: Metastatic Melanoma
Location: Portland, Oregon
- Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder
Conditions: Bursitis - Tendonitis - Shoulder Pain
Location: Gresham, Oregon
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Clackamas, Oregon
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Gresham, Oregon
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Milwaukie, Oregon
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Portland, Oregon
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Vancouver, Washington
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Milwaukie, Oregon
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Portland, Oregon
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Portland, Oregon
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Vancouver, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Vancouver, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Vancouver, Washington
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Clackamas, Oregon
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Gresham, Oregon
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Milwaukie, Oregon
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Oregon City, Oregon
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Portland, Oregon
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: The Dalles, Oregon
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Conditions: Neoplasms, Breast
Location: Portland, Oregon
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Portland, Oregon
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid
Location: Vancouver, Washington
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid
Location: Vancouver, Washington
- A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Conditions: Metastatic Breast Cancer - Advanced Breast Cancer - Gastrointestinal Stromal Tumor - Hepatocellular Carcinoma - Metastasizing Breast Cancer (F) - Metastatic Castration-Resistant Prostrate Cancer - Metastatic Renal Cell Cancer - Non Small Cell Lung Cancer
Location: Portland, Oregon
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Clackamas, Oregon
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Milwaukie, Oregon
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Oregon City, Oregon
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Portland, Oregon
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Vancouver, Washington
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Vancouver, Washington
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: Gresham, Oregon
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Vancouver, Washington
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Vancouver, Washington
- Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer
Conditions: Small Cell Lung Cancer
Location: Portland, Oregon
- A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer
Conditions: Breast Cancer, - Advanced Solid Tumors, - Cowden Syndrome
Location: Vancouver, Washington
- Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Conditions: Lung Cancer
Location: Clackamas, Oregon
- Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Conditions: Lung Cancer
Location: Portland, Oregon
- Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Conditions: Lung Cancer
Location: Vancouver, Washington
- Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Conditions: Lung Cancer
Location: Vancouver, Washington
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Vancouver, Washington
- Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Conditions: Esophageal Cancer
Location: Clackamas, Oregon
- Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Conditions: Esophageal Cancer
Location: Portland, Oregon
- Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Conditions: Esophageal Cancer
Location: Vancouver, Washington
- Chemotherapy and Radiation in Treating Patients With Stage 3 Non-Small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer
Location: Vancouver, Washington
- Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-
Conditions: Metastatic Breast Cancer
Location: Portland, Oregon
- Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndromes - Lymphoma - Multiple Myeloma - Leukemia, Myelomonocytic, Chronic
Location: Vancouver, Washington
- Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndromes - Lymphoma - Multiple Myeloma - Leukemia, Myelomonocytic, Chronic
Location: Yakima, Washington
- A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
Location: Vancouver, Washington
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Vancouver, Washington
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Vancouver, Washington
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Clackamas, Oregon
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Gresham, Oregon
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Milwaukie, Oregon
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Oregon City, Oregon
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Portland, Oregon
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: The Dalles, Oregon
- Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Location: Vancouver, Washington
- An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome
Conditions: Carcinoid Syndrome
Location: Portland, Oregon
- Capecitabine, Gemcitabine, and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer
Location: Clackamas, Oregon
- Capecitabine, Gemcitabine, and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer
Location: Milwaukie, Oregon
- Capecitabine, Gemcitabine, and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer
Location: Oregon City, Oregon
- Capecitabine, Gemcitabine, and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer
Location: Portland, Oregon
- Capecitabine, Gemcitabine, and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer
Location: Vancouver, Washington
- Capecitabine, Gemcitabine, and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer
Location: Vancouver, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Vancouver, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Vancouver, Washington
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Clackamas, Oregon
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Milwaukie, Oregon
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Oregon City, Oregon
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Portland, Oregon
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women
Conditions: Breast Cancer
Location: Gresham, Oregon
- Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
Location: Vancouver, Washington
- Study of Immunotherapy to Treat Advanced Prostate Cancer
Conditions: Prostate Cancer
Location: Portland, Oregon
- Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Clackamas, Oregon
- Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Gresham, Oregon
- Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Milwaukie, Oregon
- Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Oregon City, Oregon
- Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Portland, Oregon
- Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Vancouver, Washington
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Vancouver, Washington
- Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Conditions: Kidney Neoplasms
Location: Vancouver, Washington
- Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Conditions: Kidney Neoplasms
Location: Portland, Oregon
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
Location: Gresham, Oregon
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Clackamas, Oregon
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Gresham, Oregon
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Portland, Oregon
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Vancouver, Washington
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Vancouver, Washington
- Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Gresham, Oregon
- Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Clackamas, Oregon
- Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Portland, Oregon
- Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Vancouver, Washington
- Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Vancouver, Washington
- Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
Conditions: Brain and Central Nervous System Tumors - Neurotoxicity
Location: Gresham, Oregon
- Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer (Cetuximab Closed as of
Conditions: Lung Cancer
Location: Portland, Oregon
- Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer Afte
Conditions: Cervical Cancer
Location: Portland, Oregon
- Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Conditions: Liver Cancer
Location: Gresham, Oregon
- A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment
Conditions: Non-Hodgkin's Lymphoma
Location: Portland, Oregon
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Clackamas, Oregon
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Milwaukie, Oregon
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Oregon City, Oregon
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Portland, Oregon
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: The Dalles, Oregon
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Vancouver, Washington
- Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Cape
Conditions: Pancreatic Cancer
Location: Clackamas, Oregon
- Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Cape
Conditions: Pancreatic Cancer
Location: Gresham, Oregon
- Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Cape
Conditions: Pancreatic Cancer
Location: Portland, Oregon
- Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Cape
Conditions: Pancreatic Cancer
Location: Vancouver, Washington
- Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Cape
Conditions: Pancreatic Cancer
Location: Vancouver, Washington
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
Location: The Dalles, Oregon
- Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Clackamas, Oregon
- Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Portland, Oregon
- Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Vancouver, Washington
- Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Vancouver, Washington
- Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Conditions: Chronic Lymphocytic Leukemia
Location: Portland, Oregon
- Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Conditions: Chronic Lymphocytic Leukemia
Location: Vancouver, Washington
- High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer
Location: Gresham, Oregon
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response
Conditions: Attention-Deficit/Hyperactivity Disorder
Location: Gresham, Oregon
- Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
Location: Vancouver, Washington
- A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic B
Conditions: Breast Cancer
Location: Portland, Oregon
- Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
Conditions: Thrombocytopaenia
Location: Vancouver, Washington
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Vancouver, Washington
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Vancouver, Washington
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Clackamas, Oregon
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Milwaukie, Oregon
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Oregon City, Oregon
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Portland, Oregon
- A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positiv
Conditions: Non Squamous Lung Cancer
Location: Gresham, Oregon
- A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positiv
Conditions: Non Squamous Lung Cancer
Location: Portland, Oregon
- A Study of Pemetrexed & Carboplatin/Cisplatin or Gemcitabine & Carboplatin/Cisplatin With or Without IMC-1121B in Patients Previously Untreate
Conditions: Carcinoma, Non-Small-Cell Lung
Location: Vancouver, Washington
- OrthoIllustrated Web Based Orthopaedic Sports Medicine Registry
Conditions: Degenerative and Traumatic Pathology of the Knee - Degenerative and Traumatic Pathology of the Shoulder - Degenerative and Traumatic Pathology of the Foot and Ankle
Location: Oregon City, Oregon
- Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrex
Conditions: Cancer
Location: Vancouver, Washington
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer
Location: Vancouver, Washington
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer
Location: Vancouver, Washington
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer
Location: Clackamas, Oregon
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer
Location: Portland, Oregon
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Conditions: Kidney Cancer
Location: Vancouver, Washington
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Conditions: Kidney Cancer
Location: Vancouver, Washington
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Conditions: Kidney Cancer
Location: Clackamas, Oregon
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Conditions: Kidney Cancer
Location: Milwaukie, Oregon
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Conditions: Kidney Cancer
Location: Oregon City, Oregon
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Conditions: Kidney Cancer
Location: Portland, Oregon
- Single Agent Ofatumumab Vs. Single Agent Rituximab in Follicular Lymphoma Relapsed After Rituximab-Containing Therapy
Conditions: Lymphoma, Follicular
Location: Portland, Oregon
- Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Conditions: Type 2 Diabetes
Location: Gresham, Oregon
- Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous Melanoma
Conditions: Melanoma - NY-ESO-1-positive - Progressive Metastatic Cutaneous Melanoma - Unresectable
Location: Portland, Oregon
- Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
Conditions: Head and Neck Cancer
Location: Clackamas, Oregon
- Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
Conditions: Head and Neck Cancer
Location: Portland, Oregon
|